The aim is to evaluate when brain biopsy should be used in diagnosing atypical lesions in multiple sclerosis.
Review of cases involving atypical lesions in multiple sclerosis
Assessment of diagnosis accuracy using brain biopsies
Analysis of clinical monitoring practices
Brain biopsies may reveal atypical lesions not seen in standard tests
Improved diagnosis accuracy with targeted clinical monitoring
Highlight the necessity for timely interventions based on biopsy results
Abstract
Brain biopsy is rarely required in patients with MS; however, it should be considered in cases of atypical lesion development, underscoring the need for meticulous clinical monitoring.